Edition:
India

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

4.94USD
1:30am IST
Change (% chg)

$-0.06 (-1.20%)
Prev Close
$5.00
Open
$4.99
Day's High
$4.99
Day's Low
$4.87
Volume
89,840
Avg. Vol
329,482
52-wk High
$9.86
52-wk Low
$1.13

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: --
Market Cap(Mil.): $220.52
Shares Outstanding(Mil.): 31.75
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -1.11 -- --
ROI: -85.78 14.84 14.38
ROE: -92.43 16.34 16.07

BRIEF-Marinus Pharmaceuticals Provides Business Update And 2017 Financial Results

* MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND 2017 FINANCIAL RESULTS

06 Mar 2018

BRIEF-Marinus Pharmaceuticals files for mixed shelf of up to $200 mln

* Marinus Pharmaceuticals Inc - files for a mixed shelf of up to $200 million - SEC filing‍​ Source text: [http://bit.ly/2z23P1a] Further company coverage:

01 Nov 2017

BRIEF-Marinus Pharmaceuticals qtrly loss per share $0.15‍​

* Marinus Pharmaceuticals provides business update and reports third quarter 2017 financial results

31 Oct 2017

Earnings vs. Estimates